Midwest Institute for Clinical Research
Indianapolis, Indiana, United States
Medical clinic in Indianapolis, Indiana
8803 N Meridian St #200, Indianapolis, IN 46260
About Midwest Institute for Clinical Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
8
Pfizer
8
NewAmsterdam Pharma
3
Boehringer Ingelheim
2
Idorsia Pharmaceuticals Ltd.
2
Ionis Pharmaceuticals, Inc.
2
Kowa Research Institute, Inc.
2
Ligand Pharmaceuticals
2
NeuroBo Pharmaceuticals Inc.
2
Aegerion Pharmaceuticals, Inc.
1
Altimmune, Inc.
1
Clinical Trials at Midwest Institute for Clinical Research
During the past decade, Midwest Institute for Clinical Research conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 25 clinical trials were completed, i.e. on
average, 92.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 15 clinical trials were completed. i.e. 214.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
2005-09-01
2006-09-01
Completed
152
A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients
2003-09-01
Completed
1,109
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)
2002-07-01
Completed
805
Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia
2005-11-01
Completed
150
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
2006-07-01
2007-03-01
Completed
The Effect of Betahistine on Body Weight in Obese Subjects
2007-01-01
2007-06-01
Completed
280
AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
2007-04-01
2008-10-01
Completed
157
A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension
2008-03-01
2008-12-01
Completed
261
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Midwest Institute for Clinical Research" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 8 trials
sponsored, "NewAmsterdam Pharma" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd."
with 2 trials sponsored. Other sponsors include 18 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Institute for Clinical Research"
#1 collaborator was "Medpace, Inc." with 2 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Midwest Institute for Clinical Research
According to Clinical.Site data, the most researched conditions in "Midwest Institute for Clinical Research" are
"Hypercholesterolemia" (7 trials), "Hyperlipidemia" (6 trials), "Hypertension" (6 trials), "Atherosclerotic Cardiovascular Disease" (4 trials) and "Dyslipidemias" (3 trials). Many other conditions were trialed in "Midwest Institute for Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Midwest Institute for Clinical Research
Most popular intervention types in "Midwest Institute for Clinical Research" are "Drug" (42 trials), "Other" (6 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (26 trials), "Obicetrapib" (3 trials), "Aprocitentan 25 mg" (2 trials), "Atorvastatin" (2 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Midwest Institute for Clinical Research
The vast majority of trials in "Midwest Institute for Clinical Research" are
46 trials for "All" genders.
Clinical Trials Status at Midwest Institute for Clinical Research
Currently, there are NaN active trials in "Midwest Institute for Clinical Research".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 38 completed trials in Midwest Institute for Clinical Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Midwest Institute for Clinical Research, 0 "Phase 1"
clinical trials were conducted, 27 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 2 trials that are defined as “Not Applicable".